Unknown

Dataset Information

0

An automated sampling importance resampling procedure for estimating parameter uncertainty.


ABSTRACT: Quantifying the uncertainty around endpoints used for decision-making in drug development is essential. In nonlinear mixed-effects models (NLMEM) analysis, this uncertainty is derived from the uncertainty around model parameters. Different methods to assess parameter uncertainty exist, but scrutiny towards their adequacy is low. In a previous publication, sampling importance resampling (SIR) was proposed as a fast and assumption-light method for the estimation of parameter uncertainty. A non-iterative implementation of SIR proved adequate for a set of simple NLMEM, but the choice of SIR settings remained an issue. This issue was alleviated in the present work through the development of an automated, iterative SIR procedure. The new procedure was tested on 25 real data examples covering a wide range of pharmacokinetic and pharmacodynamic NLMEM featuring continuous and categorical endpoints, with up to 39 estimated parameters and varying data richness. SIR led to appropriate results after 3 iterations on average. SIR was also compared with the covariance matrix, bootstrap and stochastic simulations and estimations (SSE). SIR was about 10 times faster than the bootstrap. SIR led to relative standard errors similar to the covariance matrix and SSE. SIR parameter 95% confidence intervals also displayed similar asymmetry to SSE. In conclusion, the automated SIR procedure was successfully applied over a large variety of cases, and its user-friendly implementation in the PsN program enables an efficient estimation of parameter uncertainty in NLMEM.

SUBMITTER: Dosne AG 

PROVIDER: S-EPMC5686280 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

An automated sampling importance resampling procedure for estimating parameter uncertainty.

Dosne Anne-Gaëlle AG   Bergstrand Martin M   Karlsson Mats O MO  

Journal of pharmacokinetics and pharmacodynamics 20170908 6


Quantifying the uncertainty around endpoints used for decision-making in drug development is essential. In nonlinear mixed-effects models (NLMEM) analysis, this uncertainty is derived from the uncertainty around model parameters. Different methods to assess parameter uncertainty exist, but scrutiny towards their adequacy is low. In a previous publication, sampling importance resampling (SIR) was proposed as a fast and assumption-light method for the estimation of parameter uncertainty. A non-ite  ...[more]

Similar Datasets

| S-EPMC8689692 | biostudies-literature
| S-EPMC7530206 | biostudies-literature
| S-EPMC5187726 | biostudies-literature
| S-EPMC3482236 | biostudies-literature
| S-EPMC6062951 | biostudies-literature
| S-EPMC4890765 | biostudies-literature
| S-EPMC4063214 | biostudies-literature